Endoscopic retrograde cholangiopancreatography through laparoscopically created gastrotomy for the management of biliary complications of Roux-en-Y gastric bypass

Bayoumi, Mustafa; Hussein, Hisham; Aziz, Badawy A Abdul; El-Raouf, Hatem S. Abd

doi:10.4103/1110-1121.194725

Cited by 2 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ERCP remains the gold standard used to both diagnose and treat stone obstruction in the main bile duct. The rate of successful bile duct catheterization and papillotomy in patients with normal anatomy is close to 90%[ 22 ]. However, transgastric ERCP is currently one of the most widely used methods for treating choledocholithiasis in patients undergoing LRYGB[ 23 ].…”

Section: Choledocholithiasismentioning

confidence: 99%

Biliary complications associated with weight loss, cholelithiasis and choledocholithiasis

Ribeiro Jr,

Tebar,

Niero

et al. 2024

World J Gastrointest Pharmacol Ther

View full text Add to dashboard Cite

Biliary complications like cholelithiasis and choledocholithiasis are more common in bariatric surgery patients due to obesity and rapid weight loss. Patients with a body mass index > 40 face an eightfold risk of developing cholelithiasis. Post-bariatric surgery, especially after laparoscopic Roux-en-Y gastric bypass (LRYGB), 30% of patients develop biliary disease due to rapid weight loss. The aim of this review is to analyze the main biliary complications that occur after bariatric surgery and its management. A review of the literature was conducted mainly from 2010 up to 2023 with regard to biliary complications associated with bariatric patients in SciELO, PubMed, and MEDLINE. Patients undergoing LRYGB have a higher incidence (14.5%) of symptomatic calculi post-surgery compared to those undergoing laparoscopic sleeve gastrectomy at 4.1%. Key biliary complications within 6 to 12 months post-surgery include: Cholelithiasis: 36%; Biliary colic/dyskinesia: 3.86%; Acute cholecystitis: 0.98%-18.1%; Chronic cholecystitis: 70.2%; Choledocholithiasis: 0.2%-5.7% and Pancreatitis: 0.46%-9.4%. Surgeons need to be aware of these complications and consider surgical treatments based on patient symptoms to enhance their quality of life.

show abstract

Section: Choledocholithiasismentioning

confidence: 99%